
General Orthopaedics
Modified release prednisone a better option at reducing morning stiffness in RA
Lancet. 2008 Jan 19;371(9608):205-14.288 patients, between the age of 18 to 80, with active rheumatoid arthritis (RA) were randomly assigned to be administered either a modified-release prednisone tablet or an immediate-release prednisone tablet. Modified-release prednisone was a safe and well tolerated drug that produced a clinically relevant reduction of morning stiffness of the joints. In addition, it provided well known therapeutic effects of immediate-release prednisone, with a convenient and more physiological dosage administration.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.